ILCA Annual Conference 2025 will be held from 19-21 November, 2025 at Hong Kong.
The ILCA25 program will explore key topics in liver cancer, from basic and translational research to clinical management for patients with primary liver cancer, including hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). Attendees will engage with the latest advances in screening, diagnosis, treatment, and survivorship.
International experts will lead in-depth presentations and interactive discussions, offering new insights on the most pressing issues in liver cancer care. With a focus on open dialogue and future perspectives, this event promises to spark paradigm shifts in both clinical practice and research.
Super early-bird rates are available until 7 April, 2025.
